Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.8K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.8K
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

3.5K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
3.5K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

73
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
73
Glaucoma: Overview01:25

Glaucoma: Overview

964
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
964
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

750
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
750
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

888
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
888

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Lotilaner Ophthalmic Solution, 0.25% to Treat <i>Demodex</i> Blepharitis in Patients Who Were Initially Misdiagnosed: A Case Series.

Clinical optometry·2026
Same author

Lotilaner ophthalmic solution 0.25% in the treatment of <i>Demodex</i> blepharitis: A case report.

SAGE open medical case reports·2026
Same author

Effects of Lotilaner Ophthalmic Solution, 0.25% on <i>Demodex</i> Blepharitis Patients with Meibomian Gland Disease.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Eye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Real-World Experience with Lifitegrast Ophthalmic Solution in Patients with Dry Eye Disease: A Provider Survey in the USA and Canada.

Ophthalmology and therapy·2025
Same author

The <i>Demodex</i> Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for <i>Demodex</i> Blepharitis.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same journal

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg.

Ophthalmology and therapy·2026
Same journal

Refractive and Visual Outcomes of SmartSight NOVA Refractive Lenticule Extraction for Myopia and Myopic Astigmatism at 3 Months: a Retrospective Case Series.

Ophthalmology and therapy·2026
Same journal

Retinal Vascular Features and Risk of Colorectal Cancer Incidence and Mortality: A Population-Based Cohort Study.

Ophthalmology and therapy·2026
Same journal

Pharmacological Characterization of a Novel Complement C3 Inhibitor Antibody Fragment.

Ophthalmology and therapy·2026
Same journal

GLP-1 Receptor Agonists and the Ocular Surface: A Narrative Review of Restoration, Remodeling, and Clinical Implications.

Ophthalmology and therapy·2026
Same journal

Fluorescein Angiography Leakage Patterns in Pachychoroid Neovasculopathy: Neovascularization or Central Serous Chorioretinopathy?

Ophthalmology and therapy·2026
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
05:46

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity

Published on: September 20, 2024

558

Classification of Presbyopia by Severity.

Marguerite B McDonald1,2,3, Melissa Barnett4, Ian B Gaddie5

  • 1NYU Langone Medical Center, New York, NY, USA. margueritemcdmd@aol.com.

Ophthalmology and Therapy
|October 28, 2021
PubMed
Summary
This summary is machine-generated.

Presbyopia affects nearly two billion people worldwide. A new classification system for mild, moderate, and advanced presbyopia is proposed to standardize diagnosis and manage patient expectations for emerging treatments.

Keywords:
Classification of presbyopiaPresbyopiaSeverity

More Related Videos

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
07:06

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Published on: March 29, 2022

2.8K
Sequential Application of Glass Coverslips to Assess the Compressive Stiffness of the Mouse Lens: Strain and Morphometric Analyses
07:56

Sequential Application of Glass Coverslips to Assess the Compressive Stiffness of the Mouse Lens: Strain and Morphometric Analyses

Published on: May 3, 2016

7.4K

Related Experiment Videos

Last Updated: Oct 15, 2025

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
05:46

Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity

Published on: September 20, 2024

558
Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients
07:06

Binocular Dynamic Visual Acuity in Eyeglass-Corrected Myopic Patients

Published on: March 29, 2022

2.8K
Sequential Application of Glass Coverslips to Assess the Compressive Stiffness of the Mouse Lens: Strain and Morphometric Analyses
07:56

Sequential Application of Glass Coverslips to Assess the Compressive Stiffness of the Mouse Lens: Strain and Morphometric Analyses

Published on: May 3, 2016

7.4K

Area of Science:

  • Ophthalmology and Optometry

Background:

  • Presbyopia, a common age-related condition, affects nearly two billion people globally.
  • Currently, there is no standardized classification system for presbyopia severity.

Purpose of the Study:

  • To propose a formal classification system for presbyopia based on severity (mild, moderate, advanced).
  • To enhance diagnostic consistency and patient expectation management for emerging therapies.

Main Methods:

  • A panel of optometrists and ophthalmologists convened virtually.
  • The panel reviewed existing literature and clinical expertise.
  • A consensus was reached on a severity-based classification framework.

Main Results:

  • A proposed classification of presbyopia into mild, moderate, and advanced categories.
  • This classification aims to standardize diagnosis across eye care providers.

Conclusions:

  • A standardized classification of presbyopia severity is needed.
  • The proposed system may improve patient care and treatment outcomes for emerging therapies.